The Effect of High- and Low-Frequency Repetitive Transcranial Magnetic Stimulation Therapy on Serum Brain-Derived Neurotropic Factor Level and Motor Ability in Ischemic Stroke Patients: A Single-Center Study by Bintang, Andi Kurnia et al.
198 https://www.id-press.eu/mjms/index
Scientific Foundation SPIROSKI, Skopje, Republic of Macedonia
Open Access Macedonian Journal of Medical Sciences. 2020 Mar 06; 8(B):198-204.
https://doi.org/10.3889/oamjms.2020.3531
eISSN: 1857-9655
Category: B - Clinical Sciences
Section: Neurology
The Effect of High- and Low-Frequency Repetitive Transcranial 
Magnetic Stimulation Therapy on Serum Brain-Derived Neurotropic 
Factor Level and Motor Ability in Ischemic Stroke Patients: A 
Single-Center Study
Andi Kurnia Bintang1, Muhammad Akbar1, Muhammad Yunus Amran1*, Nurussyariah Hammado2
1Department of Neurology, Faculty of Medicine,, Universitas Hasanuddin; Brain Centre, Dr. Wahidin Sudirohusodo General 
Hospital, and Universitas Hasanuddin Teaching Hospital, Makassar, South Sulawesi, Indonesia; 2Department of Sports 
Coaching Education, Faculty of Sport Sciences, Universitas Negeri Makassar, Makassar, South Sulawesi, Indonesia
Abstract
BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) is widely used in various neurological cases. 
rTMS is an effective method of restoration in patients with disability due to central nervous system disorder.
AIM: This study aimed to determine the effect of high and low frequency of rTMS on serum brain-derived neurotropic 
factor (BDNF) levels and motoric abilities in ischemic stroke patients.
METHODS: The study design was an experiment with a purposive sampling consecutive on 27 samples with the 
onset of ischemic stroke 6 months. The study was conducted from February to October 2018; samples were recruited 
from Neurology Ward of Wahidin Sudirohusodo hospital and its affiliating centers. The serial of rTMS intervention 
was delivered in “Brain” Clinic center. After fulfilling the inclusion criteria and the initial examination of serum BDNF 
and motor ability, samples were randomly divided into two groups, intervention group who received standard therapy 
with rTMS therapy (n = 14) and the control group who only received standard therapy (n = 13). rTMS was given 
for 2 min frequency of 1 Hertz (Hz) contralesion and 5 Hz ipsilesion every day for 10 days. Assessment of serum 
BDNF levels and motor skills was conducted on days 1 and 10 of the study. Serum BDNF levels were measured 
by the monoclonal antibody ELISA technique while motor skills were measured based on the score of the Stroke 
Rehabilitation Assessment of Movement (STREAM). Serum BDNF values and the STREAM delta score were 
compared between the two groups of samples.
RESULTS: The results showed significant changes only occurred in motor abilities in both groups of samples after 10 
days of rTMS therapy with the Wilcoxon test (p < 0.5). The Mann–Whitney U-test showed a more significant change 
(p < 0.5) in the treatment group than in the control (p = 0.5).
CONCLUSION: rTMS has an effect on improving motor ability in ischemic stroke patients. This change in motor 
abilities is not related to serum BDNF levels in this study.
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Introduction
Stroke is a health problem the whole world, the 
incidence rate is increasing and is the leading cause of 
disability. It was reported that, in 2013, globally, there 
were 2.57 million people stroke survivors worldwide, 
6.5 million people died from stroke, 113 million people 
have disability-adjusted life years due to stroke, and 
10.3 million have new cases of stroke [1]. In Indonesia, 
the incidence of stroke also increases sharply. Data 
from the 2018 Riset Kesehatan Dasar (Riskesdas) on 
population aged ≥15 years by province stated that the 
prevalence of stroke increased from 7/1000 in 2013 
to 10.9/1000 in 2018. At Dr. Wahidin Sudirohusodo 
Hospital in Makassar, South Sulawesi, Indonesia, stroke 
ranks highest in the number of hospitalized patients [2]. 
Ischemic stroke incidence is higher at 89.9% compared 
to 10.1% hemorrhagic stroke.
In general, the affected blood vessels are the 
media and anterior cerebral arteries which give blood 
supply to the area of the brain that regulates motor 
skills and speech, so neurological deficits are more 
often motoric disorders, such as difficulty moving the 
hands and feet. This condition will certainly lead to 
limitations in carrying out daily activities, ranging from 
simple activities, such as holding, raising hands, to 
more complex motor activities, such as eating, changing 
clothes, brushing teeth, and walking. Functional 
stimulation of the cerebral cortex, both magnetic and 
electrical, is considered as one of the restoration 
techniques that can improve functional ability in 
patients, especially if accompanied by intensive motor 
exercises [3].
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Transcranial magnetic stimulation (TMS) is a 
non-invasive method that uses magnetic fields to stimulate 
neuron cells in the brain and record stimulus responses 
using electromyography. The effect of repetitive TMS 
(rTMS) on modulating brain plasticity is followed by 
increased levels of BDNF which plays an important role 
in neurogenesis, migration, and differentiation of neuron 
cells, synaptogenesis, and angiogenesis, such as nerve 
growth factor and vascular endothelial growth factor. 
Excitatory stimulation in the ipsilesion region is associated 
with changes in neurotransmitters and neurotropic 
factors [4]. However, whether changes in BDNF levels 
independently after rTMS therapy are directly related to 
changes in motor functional ability after ischemic stroke 
is still unclear. Therefore, this study aims to see whether 
there is a relationship between BDNF levels and motor 
functional abilities after high- and low-frequency rTMS 
therapy in ischemic stroke patients.
Materials and Methods
Study location and time
This study was conducted from February to 
October 2018. The study samples were collected at the 
Inpatient Neurology Unit of Dr. Wahidin Sudirohusodo 
Hospital. Repetitive TMS therapy was carried out in 
“Brain” TMS Clinic and blood specimen analyzing was 
carried out in Laboratorium of Universitas Hasanuddin 
Hospital, Makassar City, South Sulawesi, Indonesia.
Study design and variables
This study was a randomized, controlled, pre-
posttest experiment in a single center comparing the 
effect of standard ischemic stroke therapy in combination 
with rTMS intervention. The study protocol was approved 
by the Ethics Committees of Medical Faculty, Universitas 
Hasanuddin. All study samples were provided written 
informed consent and approval prior participating. Detail 
study flows are described in Figure 1.
Population and samples
The population of this study were all ischemic 
stroke patients who were hospitalized at Wahidin 
Sudirohusodo Hospital, Makassar, Indonesia. The study 
samples were patients with first attack stroke with onset 
time of 1–6 months and were obtained by consecutive 
sampling until the number of patients needed was fulfilled.
Inclusion and exclusion criteria
Patients were included in the study if fulfilled 
the inclusion criteria of having a diagnosis of ischemic 
stroke based on clinical symptoms and CT head scan 
results without contrast. Patients with hemiparesis 
with mild-moderate clinical disorder (mRS ≤ 4) due to 
damage to the unilateral brain hemisphere associated 
with ischemic stroke. Stroke onset was more than 1 
month. The age of the patient ranges from 35 to 80 
years and willing to participate by signing an informed 
consent. Samples were exclude if they have a history 
of using implantable pacemakers; hemorrhagic stroke 
or transient ischemic attack (TIA); ischemic stroke with 
severe clinical disorders; epilepsy; history of heart, 
lung, and liver; kidney failure; and cognitive impairment.
Randomization
The study samples were recruited from the 
inpatient unit of stroke ward in one hospital. Randomization 
was performed with random pick-up from the samples 
name list after the confirmation of patient eligibility before 
the study begun. Samples were randomly assigned into 
one of two groups, i.e., intervention group (standard 
ischemic stroke therapy + rTMS) and control group 
(standard ischemic stroke therapy alone). Samples 
were identified by sequential numbers assigned at 
randomization. The sample assignment notice was sent 
only to physician who performed the rTMS intervention. 
The patients were blinded to group assignment until the 
study was completed.
Figure 1: Study flow
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Data collection methods
Data are obtained in the primary way. Samples 
were given an explanation of the study. If they agreed, 
they have been asked to sign an informed consent 
following the study. History taking of the study sample 
was carried out, a physical examination was performed 
to diagnose ischemic stroke and a definitive diagnosis 
was established based on a non-contrast head CT scan 
image assessed by a radiologist. Indonesian version of 
the Montreal cognitive assessment was performed to 
exclude severe cognitive impairment and examination 
of functional motor skills with the Stroke Rehabilitation 
Assessment of Movement (STREAM) score for motor 
impairment grading.
Repetitive TMS
The treated samples were treated with rTMS 
intervention after they were hospitalized, in 2 cycles. 
Each cycle is carried out for 5 consecutive days with 
a delay of 2 days and then followed by the 2nd cycle 
for 5 consecutive days. rTMS targets stimulation in the 
primary motor area (M1). In the hemisphere area of 
the ipsilesion cerebral, rTMS is carried out with a high 
frequency of 5 Hz while in the contralesion hemisphere 
a low-frequency stimulus of 1 Hz is given. Stimulation 
is given 3 beats (pulse) per 1 s burst (stimulus). Each 
hemisphere received 20 series of stimulus for 10 s 
followed by a resting interval of 2 s between stimulations 
so that each hemisphere cortex received 600 stimulus. 
The intensity of the ipsilesion hemisphere stimulus is 
75% and the contralesion is 90% motor threshold (MT).
Data analysis technique
The data obtained were analyzed using the 
SPSS 21 statistical test that uses Pearson’s statistical 
test. Assessment of hypothesis testing was stated as 
significant if p ≤ 0.05.
Ethics statement
The study was performed following the principles 
of the Declaration of Helsinki. Participation in the study 
was fully voluntary and anonymous and was approved 
by the Ethics Commission for Medical Research of 
Faculty of Medicine, Universitas Hasanuddin.
Results
Demographic data and patient 
characteristics
Table 1 shows the distribution of subjects 
by sex, age, time of onset of stroke, degree of motor 
impairment, the STREAM score with a description 
of several domains, and BDNF serum levels. The 
study subjects consisted of 14 (54.16%) males and 
13 (45.84%) females with an overall age average of 
58.87 (±8.43) which there was no significant difference 
in mean age in the treatment and control groups 
(p = 0.332). The mean onset of stroke in the treatment 
and control groups was 40.43 (±37.502) and 45.62 
(±33.604) days and this difference was not significant 
(p = 0357). The mean BDNF serum levels did not 
differ in the two groups (p = 0.409), which were 3.0170 
(±1.313) in the treatment group and 3.688 (±1.019) in 
the control group. There was no significant difference 
between the treatment group and control group for the 
first measurement value on the paresis side variable, 
STREAM EU score, STREAM LE score, and STREAM 
mobility score.
Comparison of the STREAM scores on 
the basic motor skills of upper extremity (UE) and 
Lower extremity (LE) between the treatment and 
control groups
Table 2 shows that the mean score of the basic 
UE motor skills in the treatment group (9.50 [± 3.156]) 
and controls (6.69 [±4.78]) in the measurement I. There 
was an increase in mean motor score measurement 
II in the two study groups, but the difference in 
measurements I and II for the basic UE motor skills 
score in the treatment group (3.07 [± 1.33]) and controls 
(2.77 ± 2.28) did not show significant differences 
(p = 0.204) and the mean score of LE basic motor skills 
in the treatment group (11.00 [± 2.88]) and controls (8.23 
[± 3.83]) in measurement I. It also showed an average 
increase in motor score measurement II in both the 
study groups, but the difference in measurements I and 
II for the score of LE basic motor skills in the treatment 
group (3.86 [±2.41]) and controls (2.54 [± 2.18]) did not 
show a significant difference (p = 0.325).
Comparison of mobility scores between 
the treatment and control groups
Table 3 shows an analysis of the comparison 
of changes in the STREAM score in the component 
Table 1: Characteristics of the study sample
Variables Treatment (n=14) Control (n=13) p-value
Gender
Male (n=14; %) 6 (42.85) 8 (61.53) 0.332
Female (n=13; %) 8 (57.15) 5 (38.47)
Age (year; mean ± SD) 54.50 (± 8.591) 62.15 (± 6.530) 0.357
Onset (day; mean ± SD) 40.43 (± 37.502) 45.62 (± 33.604) 0.706
STREAM score
UE (mean ± SD) 9.50 (± 3.156) 6.69 (± 4.785) 0.179
LE (mean ± SD) 11.00 (± 2.882) 8.23 (± 3.833) 0.379
Mobility (mean ± SD) 11.50 (± 4.911) 10.08 (± 5.361) 0.550
Total score (mean ± SD) 32.14 (± 10.007) 25.00 (± 13.080) 0.386
Degree of motor impairment
Severe (n; %) 4 (28.57) 8 (61.54) 0.98
Moderate (n; %) 9 (64.28) 3 (23.08)
Mild (n; %) 1 (7.15) 2 (15.38)
BDNF serum levels (mean ± SD) 3.0170 (± 1.313) 3.688 (± 1.019) 0.409
mRS: Modified Rankin Scale, UE: Upper extremity, LE: Lower extremity, STREAM: Stroke Rehabilitation 
Assessment of Movement, BDNF: Brain-derived neurotropic factor, SD: Standard deviation.
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mobility of ability in the treatment and control groups. 
There was an increase in mobility ability scores in both 
groups, with an average difference of increase (5.57 
[±1.74]) in the treatment group and (2.00 [± 1.53]) 
controls, cross-tabulation test on the two difference 
values showed a significant difference (p = 0.014).
Comparison of degree motor impairment 
between the treatment and control groups
Table 4 shows that there was a tendency for 
changes in the degree of motor impairment scores in 
the two groups with the average score difference (12.93 
[±4.73]) in the treatment group and (7.31 [± 5.67]) in 
the control group. After the significance test of cross-
tabulation on the two difference values showed a 
significant difference (p = 0.05).
Comparison of serum BDNF level in the 
treatment and control groups
Table 5 shows an analysis of the comparison of 
BDNF serum levels in the treatment and control groups 
in measurements I and II. From Table 5, the mean 
serum BDNF level in measurement I in the treatment 
group was 3.017 ng/ml (±1.313), while in the control 
group ranged 3.688 ng/ml (±1.019) with the cross-
tabulation test did not show significant differences 
between the two groups. The mean difference in serum 
BDNF levels was (0.12 ng/ml [±1.072]) in the treatment 
group and (0.09 ng/ml [±0.837]) in the control group. 
Cross-tabulation test on the difference between the 
two study groups did not show a significant difference 
(p = 0.409).
Significance of serum BDNF levels on 
improving motor skills in the treatment and control 
groups
Table 6 shows the relationship between 
changes in serum BDNF levels in improving motor 
skills in the study group. From Table 6, the results of 
the Spearmen correlation test on the study data did 
not show a significant relationship between changes in 
serum BDNF levels and improvement in motor skills in 
the two study groups.
Discussion
Functional stimulation of the cerebral cortex, 
both magnetically, is one of the restoration techniques 
that can improve patient’s motor abilities, especially if 
accompanied by intensive motor exercises [3]. The 
principle of cortical facilitation with this stimulus follows the 
Hebbian neural network theory that activation of certain 
nerve cells will affect the connection of surrounding 
neural networks. Excitatory stimulation in the primary 
motor cortex region of the ipsilesion brain can increase 
functional synaptic connections with neurons in the 
pre-motor and secondary motoric regions. Otherwise, 
inhibitory stimulation in the primary motor area of the 
contralesion brain will reduce contralesion motor neuron 
activity and give ipsilesion nerve tissue the opportunity 
to strengthen synaptic bonds. Furthermore, ipsilesion 
stimulation in areas other than the primary motor area is 
also thought to induce changes in synaptic connections 
between brain regions.
A total of 27 samples met the inclusion 
criteria to be the samples of the study. Furthermore, 
the samples were divided according to the order of 
visits to the brain clinic in two groups, namely, the 
treatment group (n = 14) and control (n = 13) until the 
total sample fulfilled. Samples in the treatment group 
received rTMS intervention in 2 cycles. In the ipsilesion 
cerebral hemisphere area, rTMS is carried out with 
a high frequency of 5 Hz while in the contralesion 
hemisphere is given a low-frequency stimulus of 
1 Hz, which refers to the interhemispheric balance 
theory [5], [6]. The intensity of ipsilesion stimulation is 
75% and contralesion 90% MT.
The samples in the control group only received 
standard therapy, namely, medical and physiotherapy. 
Two methods of sham rTMS for the control group often 
used in the rTMS study are as follows: (1) Control 
samples were given rTMS with a frequency of <1 Hz with 
intensity below the MT (sub-MT) [7] and (2) the control 
sample received rTMS with the location of the coil plate 
vertical to the scalp or did not touch the scalp but the 
sample still heard the sound “ta..ta.ta” when stimulation 
was carried out [6], [8]. One rTMS study in subacute 
ischemic stroke patients suggested that even repeated 
stimulation from low-frequency rTMS <1 Hz can still 
have an inhibitory effect on stimulated areas [9], [10].
Table 2: Analysis of the comparison of the STREAM scores on the basic motor skills of UE and LE in the treatment and control 
groups
Basic motor skills Treatment (n=14) Control (n=13) p-value
Measurement I Measurement II Δ score Measurement I Measurement II Δ score
UE (mean ± SD) 9.50(± 3.156) 12.57(± 3.20) 3.07(± 1.33) 6.69(± 4.78) 9.46(± 4.61) 2.77(± 2.28) 0.204
LE (mean ± SD) 11.00(± 2.88) 14.86(± 2.35) 3.86(± 2.41) 8.23(± 3.83) 10.77(± 3.61) 2.54(± 2.18) 0.325
Source: Primary data; statistical analysis was carried out by Chi-square test. LE: Lower extremity, UE: Upper extremity.
Table 3: Comparison analysis of the treatment and control groups mobility ability scores
Mobility skills Treatment (n=14) Control (n=13) p-value
Measurement I Measurement II Δ score Measurement I Measurement II Δ score
Mobility (mean ± SD) 11.50 (± 4.91) 17.07 (± 5.41) 5.57 (± 1.74) 10.08 (± 5.36) 12.08 (± 4.77) 2.00 (± 1.53) 0.014
Source: Primary data; statistical analysis was carried out by Chi-square test.
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Age and gender are often associated with 
the prevalence of ischemic stroke. In this study, the 
variable control was carried out in the age group, risk 
factors, and other factors, such as therapy obtained 
by the sample. Statistical analysis on demographic 
data obtained p > 0.05, which concluded that the 
demographic variables did not differ significantly in 
the two groups. These results also show similar things 
about demographic data in the previous study. Data 
on the 2011 stroke guidelines from Pokdi Perdossi 
showed that the highest incidence of stroke was in the 
age range of 45–64 years (54.2%) and the incidence 
in male was higher than in female and also similar to 
the previous stroke and rTMS studies conducted by 
Hosomi et al. which showed that the average age of the 
study samples was 62.4 (±15.5) [7].
Table 6: Analysis of the significance of serum BDNF levels on 
improving motor skills in the treatment and control groups
Spearman’s rho Delta BDNF serum Delta KMF
Delta BDNF serum Correlation coefficient 1.000 −0.063
Sig. (two tailed) - 0.756
n 27 27
Delta KMF Correlation coefficient −0.063 1.000
Sig. (two tailed) 0.756 -
n 27 27
Source: Primary data; statistical analysis was carried out by Chi-square test. BDNF: Brain-derived 
neurotropic factor.
Ischemia in the brain triggers a change in 
the organ structure of brain tissue that influences the 
mechanism of recovery motor skills after a stroke. The 
current hypothesis states that local reorganization 
occurs due to takeover of functions or vicarization [11], 
tissue damaged by intact tissue in peri-infarct regions, 
this mechanism is also known as peri-regional 
organization. The stages of local reorganization in 
brain tissue take place in the acute-subacute phase for 
approximately 1–12 weeks and facilitate spontaneous 
functional recovery [4]. Until the end of the 12th week, 
neuron in the ipsilesion area continued to show a 
decrease in excitation ability and survival indicating the 
possibility of other mechanisms involved in restoring 
motor abilities after stroke that could potentially involve 
the secondary motor cortex [12].
This study uses an assessment instrument 
of the Stroke Rehabilitation Assessment of Movement 
(STREAM) to assess the degree of motor impairment 
after stroke [13]. The STREAM instrument has three 
assessment subscales, namely, voluntary movement 
of superior extremities, voluntary movements of inferior 
extremities, and basic mobilities, such as clenching, 
grasping, lying down, sitting, and walking. The 
maximum total score for all subscales is 70. The basic 
motor ability of the samples was seen in the STREAM 
subscale scores of the superior and inferior extremities. 
In general, the data of this study showed an increase in 
all scores of the STREAM subscales in both groups, but 
the results of statistical analysis of these data showed 
significant differences only in the components of motor 
mobility and not in basic motor abilities. The mean 
score of the inferior extremity STREAM measured on 
the 1st day and day 10 was higher than the superior 
extremities in both groups. This is parallel with the 
study conducted by Li et al. who assessed the effect of 
rTMS on improving motor function in subacute ischemic 
stroke. In his study, Li reported that improvement in 
motor dysfunction in the superior extremities tended to 
be slower than recovery in the inferior extremities [6]. 
A different matter was suggested by Chang et al. in 
a study conducted to assess the long-term effect of 
rTMS on recovery of motor function in 28 subacute 
ischemic stroke patients. From the study data, Chang 
concluded that there was no significant difference 
found in the hand and foot motor skills after being given 
rTMS therapy. The difference in results obtained by 
Chang et al. with this study can be explained because 
of the different stimulation methods used. Chang 
et al. used rTMS with a high frequency of 10 Hz and 
90% MT intensity only in ipsilesion [8]. The balance 
theory of interhemispheric suggests that stimulation 
on one side of the hemisphere can interfere with 
transcallosal mutual inhibition-excitation in both of brain 
hemispheres [6]. Motor deficits after ischemic stroke 
result from a loss of inhibitory effect on the contralesion 
hemisphere cortex [5]. rTMS facilitates reorganization 
of the motor cortex through regulation of neuron and 
synaptic excitability [3].
A systematic review study of the Cochrane data 
base regarding the efficacy of rTMS and improvement 
in functional ability after stroke suggested that 
administration of rTMS interventions did not show a 
significant increase in clinical outcome improvement as 
measured by the Barthel index in stroke patients [14]. This 
systematic review study further concludes that existing 
scientific evidence does not suggest the use of rTMS as 
a routine therapy after stroke, although this study still 
provides recommendations for further research on the 
therapeutic effects of rTMS on improving motor skills in 
ischemic stroke patients. However, the data obtained 
from the results of this study showed that repeated 
Table 4: Comparative analysis of the degree motor impairment in the treatment and control groups
Motor skills disorder (Mean±SD) Treatment (n=14) Control (n=13) p-value
Measurement I Measurement II Δ score Measurement I Measurement II Δ score
Motoric impairment degree 32.4 (±10.07) 45.07 (±9.27) 12.93 (±4.7) 25.0 (±13.08) 32.31 (±11.89) 7.31 (±5.6) 0.05
Source: Primary data; statistical analysis was carried out by Chi-square test.
Table 5: Comparative analysis of serum BDNF levels in the treatment and control groups
BDNF serum level, ng/ml Treatment (n=14) Control (n=13) p-value
Measurement I Measurement II Δ score Measurement I Measurement II Δ score
BDNF serum (mean±SD) 3.017 (±1.313) 3.136 (±1.41) 0.12 (±1.072) 3.688 (±1.02) 3.781 (±2.13) 0.09 (±0.837) 0.409
Source: Primary data; statistical analysis was carried out by Chi-square test. BDNF: Brain-derived neurotropic factor.
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TMS interventions for 10 consecutive days with 5 Hz 
ipsilesion stimulation frequency and 1 Hz contralesion 
and 75% intensity affected the motor skills of the first 
attack ischemic stroke patients with onset <6 months.
Efforts were made to reduce the bias toward 
the results of the study obtained, namely, by “matching” 
the demographic variables of age, gender, onset, risk 
factors, and standard therapy including the use of drugs. 
The limitation of this study is the difficulty of controlling 
physiotherapy after outpatient care. The assessment of the 
STREAM score is only carried out by one person so that the 
scores obtained can be overestimated or underestimated.
In the studies of Schmolesky et al and Cho et al 
that involves measuring and validating the basal serum 
of BDNF values stated that the levels of basal BDNF 
values were ranged from 22.94 ± 9.12 ng / mL - 24.95 ± 
7.28 ng / ml in healthy male and female populations [15]. 
Low serum BDNF levels are found in people with a 
tendency toward behavioral mental disorders, such as 
anxiety, panic attacks, depression, memory disorders, 
and schizophrenia. The other studies have also linked 
low serum BDNF levels with Alzheimer’s and diseases 
associated with vascular disorders.
BDNF is a factor that plays an important role in 
the mechanism of neurogenesis and synaptogenesis, 
especially after brain tissue injury, such as ischemic 
stroke. BDNF levels are found in serum and peripheral 
plasma circulation. Research on serum BDNF levels 
in stroke patients has also been carried out [7], [16]. 
In general, from these studies, it was concluded that 
the factors that influence serum BDNF levels are gene 
BDNF polymorphism so that changes in serum BDNF 
levels after rTMS therapy will be affected in a way by 
BDNF gene polymorphism [16], [17].
The plasticity character of the brain is used in the 
principle of remodeling and recruitment in the area after 
ischemia. There are three main forms of reorganization 
that have been described: (1) Increase cortical 
excitability in the remote cortex, but still connected to the 
core of the stroke; (2) reduce lateralization activity; and 
(3) somatotopic modification in intact cortex regions [3]. 
Hoping that stimulation with different frequencies in 
both brain hemispheres can trigger rebalancing of brain 
excitation-inhibition and affect motor improvement. 
Changes in serum BDNF levels are also expected to 
affect neurogenesis and synaptogenesis so that cortical 
somatotopic remodeling in both hemispheres can occur. 
The results of statistical tests conducted on this study 
data indicate that there is an improvement in the degree 
of motor impairment after repeated TMS in the treatment 
group, but this improvement does not related to changes 
in serum BDNF levels. The results of the same study 
were also shown in the previous studies [18]. This may 
be due to many factors that contribute to post-stroke 
motoric improvement.
A study was carried out in Japan to evaluate the 
effect of BDNF level in improving superior extremities 
skills after rTMS therapy. The study was conducted on 
a total of 62 samples with low-frequency stimulation 
of 1 Hz in the somatotopic region of the interosseous 
dorsalis contralesion muscle for 14 days. In another 
study group, rTMS therapy was combined with standard 
physical rehabilitation therapy. The clinical outcome of 
motor ability is measured using the Fugl-Meyer scale 
and Wolf Motor Function. The peripheral blood samples 
of the study samples were collected and measurements 
were taken on polymorphism BDNF, pro-BDNF, and 
Matrix metalloproteinase (MMP-9) levels. The results of 
the study concluded that the combination of standard 
rTMS therapy and physical rehabilitation increased 
serum BDNF levels and MMP-9 but were not related 
to improvement in motor skills of the study samples. 
The researcher also concluded that standard rTMS 
interventions did not affect BDNF gene polymorphism 
[7]. In this study, the administration of rTMS therapy 
was carried out with the same protocol toward all 
treated samples and did not based on the reference of 
BDNF gene polymorphism. Another study by Hwang 
et al. also showed that BDNF genotype differences 
could influence differences in response to rTMS [18]. In 
future, it may be necessary to take an individual dose of 
rTMS therapy refer to this BDNF gene diversity. 
Conclusion
rTMS has an effect on improving motor ability in 
ischemic stroke patients on the first attack on ≤6 months 
which this change is greater in the treatment group than 
in the control group. Improvement in motor skills does 
not related to serum BDNF levels in this study. rTMS 
does not affect serum BDNF levels in ischemic stroke 
patients. The practical benefit of this study is to support 
the existence of literature that states the contribution of 
rTMS intervention as adjuvant therapy in patients with 
motor stroke impairment after ischemic stroke.
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